Skip to main content

The Global Kidney Cancer Drugs Market Is Witnessing High Growth Owing To the Increasing Prevalence of Kidney Cancer Cases in the World

 


Market Overview:

Kidney cancer is a serious medical condition. There are several types of the disease, including medullary and sarcoma, which are less common but highly aggressive. They develop in the soft tissue surrounding the kidney, as well as in the fat that surrounds it. Surgical removal of the affected organ is the standard treatment for this type of cancer. However, if the disease has spread to other organs or spreads beyond the kidney, chemotherapy or systemic therapy may be needed. A biopsy is another test for kidney cancer. It involves inserting a thin needle into a tumor and looking through the tissue under a microscope to detect cancer cells. Biopsies aren't always accurate, and the healthcare provider may not recommend them. If the tumor has spread to lymph nodes or is large, a biopsy may be performed. This will allow the doctor to evaluate the tumor's location and the extent of its spread and determine its stage and aggressiveness.

Competitive Landscape:

Major players operating in the global kidney cancer drugs market include Quest Diagnostics Incorporated, Illumina Inc, Rosetta Genomics, Sysmex Corporation, NanoString Technologies Inc, NeoGenomics Laboratories, Myriad Genetics Inc, Argos Therapeutics, Prometheus Laboratories, Immatics Biotechnologies, Aveo Pharmaceuticals, Abbott Laboratories, Onyx, Cipla Limited, Roche, Eisai, Bristol-Myers Squibb, Thermo Fisher Scientific Inc, Amgen, Active Biotech, GlaxoSmithKline Plc, Genentech Inc., F. Hoffmann-La Roche Ag, Exelixis Inc, Novartis International AG, Pfizer Inc., and Bayer AG.

Key Market Drivers:

The increasing incidence of kidney cancer cases in the world is expected to augment the growth of the global kidney cancer drugs market. For instance, according to Cancer.Net, in 2020, around 431,288 individuals in the world were suffering from kidney cancer. Targeted drug therapy uses drugs or substances to attack the cancer cells in a specific area of the body. This can reduce side effects caused by the drugs while still killing the cancer cells. Anti-angiogenic agents block the growth of the blood vessels feeding the tumor. A multikinase inhibitor can stop the growth of cancer cells, while a tyrosine kinase inhibitor works by blocking an enzyme that helps the cancer cells grow. Increasing treatment launches by key players are estimated to enhance the growth of the global kidney cancer drugs market. 

Covid-19 Impact Analysis

During the COVID-19 pandemic, the increasing focus on the virus-infected cases affected the growth of the global kidney cancer drugs market.  Moreover, sudden stress on the healthcare sector also impacted the market growth.

Key Takeaways

·         North America is expected to dominate the growth of the global kidney cancer drugs market, owing to the increasing prevalence of kidney cancer cases in the region. For instance, according to Cancer.Net, in 2020 around 79,000 adults in the U.S. were diagnosed with kidney cancer.

·         The Asia Pacific is estimated to witness high growth in the global kidney cancer drugs market, owing to the increasing expansion of cancer hospitals in the region. For instance, according to the Indian Cancer Society, India has around 27 dedicated cancer hospitals currently.

 

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis

  A primary driver for this market is the worldwide increase in occurrence of diabetes and cancer, across all age groups. According to the World Health Organization (WHO) 2018 statistics, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Moreover according to the World Health Organization cancer factsheet 2018, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018.  Furthermore, increasing old age population is another driver, which is anticipated to create a high growth scenario for the market. As per the World Population Prospects 2019 revision, the number of people aged 80 years or over is projected to be triple, from 143 million in 2019 to 426 million in 2050. Alternatively, factors restraining the market are complications and risks associated with the treatment including diarrhea, nausea, hair loss, vomiting, severe infections, infertility, and heart complications....
Post a Comment
Read more

North America is expected to lead the global cosmetology market due to growing number of minimally invasive surgeries in the region

  Market Overview: Cosmetology is the field of a beauty practice that includes a variety of practices aimed at making individual’s look and feel their best. Competitive Landscape: GC Aesthetics, Mentor Worldwide LLC, Sientra Inc., Zimmer Holdings Inc., 3M Health Care, Allergan, Inc., Implantech Associates Inc., Institut Straumann AG, Nobel Biocare Holding AG, and Spectrum Designs Medical.   Key Market Drivers: An increasing number of cosmetic surgeries is expected to expand the global cosmetology market size. For instance, according to American Society of Plastic Surgeons (ASPS) 2017 reports, around 17.5 million cosmetic surgeries were performed in 2017, U.S. among which breast augmentation, liposuction, and nose reshaping were the top three procedures. High preferences for Botox surgeries which are used to reduce wrinkles and maintain youthful skin is again fostering the growth of the market growth. According to the same source, around 65% of women prefer Botul...
Post a Comment
Read more

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others. The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027 Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers Increasing number of surgical procedures is expected to propel growth of the global surgical  hemostats , internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures sta...
Post a Comment
Read more